A triple-blinded, randomized, placebo-controlled trial to examine the efficacy of buspirone added to typical antipsychotic drugs in patients with chronic schizophrenia

BACKGROUND: The purpose of this study was to test the hypothesis that the addition of buspirone, a partial agonist of 5HT1A receptor, to ongoing treatment with typical antipsychotics would improve the positive and negative symptoms in patients with chronic schizophrenia. MATERIALS AND METHODS: In th...

Descripción completa

Detalles Bibliográficos
Autores principales: Sheikhmoonesi, Fatemeh, Zarghami, Mehran, Bahari Saravi, Seyyedeh Fatemeh, Khalilian, Alireza, Ala, Shahram
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4400707/
https://www.ncbi.nlm.nih.gov/pubmed/25983765

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4400707/
https://www.ncbi.nlm.nih.gov/pubmed/25983765

Ejemplares similares